icometrix vs Lunit
A breast screening program on tomosynthesis is Lunit's buyer. INSIGHT MMG and INSIGHT DBT hold five openFDA records under code QDQ, the newest being INSIGHT MMG v1.1.10 as K260320 on April 23, 2026. Volpara's density and positioning tools came with the acquisition Lunit announced completing on May 22, 2024, for roughly US$193 million. INSIGHT CXR and MMG received MDR CE and UKCA marks, announced November 21, 2022. For chest X-ray, Lunit's only openFDA record is INSIGHT CXR Triage, K211733.
An MS or dementia clinic comparing brain MRI across visits is icometrix's buyer. icobrain has six openFDA records from K161148 in 2016 to icobrain aria, K240712, in 2024, and the vendor's pages cover multiple sclerosis, dementia, epilepsy, stroke and traumatic brain injury. GE HealthCare announced on September 10, 2025 an agreement to acquire icometrix, with distribution planned across all vendor MRI systems, and the icometrix site banner reads "icometrix is now a GE HealthCare company".
A health system that runs both a breast screening service and a memory clinic has two separate purchases in front of it: Lunit's records cover mammography, tomosynthesis and one chest triage product, and icometrix's cover brain MRI, CT perfusion and ARIA monitoring.
Radiology · Reviewed November 2, 2026
icometrix
by icometrix NV · founded 2011
FDA-cleared icobrain AI quantifies brain structures and lesions on MRI and CT and tracks changes over time.
Lunit
by Lunit · founded 2013
AI for chest X-ray, mammography and breast tomosynthesis, Volpara breast-density tools, and pathology biomarker software (SCOPE).
When to pick each one
icometrix
- Brain MRI follow-up for MS, dementia and epilepsy
- Site banner: now a GE HealthCare company
Lunit
- Mammography and tomosynthesis 510(k)s, K211678 and K231470
- Volpara density and positioning tools
Score
Each row shows points earned of points available under the published rubric.
icometrix
68of 100
Lunit
66of 100
| Dimension | icometrix | Lunit | Difference |
|---|---|---|---|
| FDA clearance | 18 / 18 | 18 / 18 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 0 / 10 | 0 |
| EHR integrations (count) | 0 / 4.2 | 0 / 4.2 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 2.4 | 0 / 2.4 | 0 |
| Peer-reviewed papers | 18.2 / 18.2 | 12.7 / 18.2 | +5.5 |
| RCT / meta-analysis / systematic review | 3.9 / 7.8 | 7.8 / 7.8 | -3.9 |
| Funding & adoption signal | 8.4 / 12 | 8.4 / 12 | 0 |
| Pricing transparency | 2.5 / 5 | 2.5 / 5 | 0 |
| Years in market | 6 / 6 | 6 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
icometrix
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Lunit
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Contact form only. |
Evidence
icometrix
FDA decisions
K240712 (opens in new tab)510(k)2024-11-07
icobrain aria
K192962 (opens in new tab)510(k)2020-02-28
icobrain-ctp
K192130 (opens in new tab)510(k)2019-12-13
Icobrain
K181939 (opens in new tab)510(k)2018-11-06
icobrain
K180326 (opens in new tab)510(k)2018-03-08
icobrain
Show 1 more
K161148 (opens in new tab)510(k)2016-08-09
icobrain
Peer-reviewed
5 PubMed records name icometrix.
- Lecanemab in practice: AI-derived MRI predictors of benefit and Amyloid Related Imaging Abnormalities (ARIA). (opens in new tab)
- Uncovering heterogeneous cognitive trajectories in relapsing-remitting multiple sclerosis: a longitudinal study. (opens in new tab)
- Quantifying White Matter Hyperintensities: Automated Volumetry Compared with Visual Grading Scales. (opens in new tab)
Lunit
FDA decisions
K260320 (opens in new tab)510(k)2026-04-23
Lunit INSIGHT MMG (v1.1.10)
K253796 (opens in new tab)510(k)2026-03-26
Lunit INSIGHT DBT (V1.2)
K242652 (opens in new tab)510(k)2024-10-04
Lunit INSIGHT DBT v1.1
K231470 (opens in new tab)510(k)2023-11-06
Lunit INSIGHT DBT
K211678 (opens in new tab)510(k)2021-11-17
Lunit INSIGHT MMG
Show 3 more
K211733 (opens in new tab)510(k)2021-11-10
Lunit INSIGHT CXR Triage
K211279 (opens in new tab)510(k)2021-07-27
Volpara Imaging Software
K182310 (opens in new tab)510(k)2018-09-21
Volpara Imaging Software
Peer-reviewed
3 PubMed records name Lunit.
- Comparison of different Lunit INSIGHT CXR software versions when reading chest radiographs for tuberculosis. (opens in new tab)
- Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21). (opens in new tab)
- Long-term prognostic implications of AI-detected versus AI-undetected breast cancers on mammography: a propensity score-matched analysis. (opens in new tab)
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | icometrix | Lunit |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | 2011 | 2013 |
| HQ | BE | KR |
Scroll horizontally to see both columns.
Common questions
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.